Extended Adjuvant Neratinib Therapy for Patients with HER2+ Early Breast Cancer

Video

Joyce O’Shaughnessy, MD, starts a conversation on which patients with HER2+ early breast cancer are the best candidates for extended adjuvant neratinib therapy.

Related Videos
A panel of 5 experts on renal cell carcinoma
A panel of 5 experts on renal cell carcinoma
Video 4 - "Predisposition for Patients Developing DTC: Age and Gender"
Video 3 "Determining Prognosis for Patients with Differentiated Thyroid Cancer"
A panel of 6 experts on colorectal cancer
A panel of 6 experts on colorectal cancer
Video 1 - "HR+/HER2- Early-Stage Breast Cancer: Background and Risk Stratification "
Lori A. Leslie, MD, an expert on lymphoma